Cytokinetics Inc

NASDAQ:CYTK   1:43:02 PM EDT
49.83
-0.97 (-1.91%)
Earnings Announcements

Cytokinetics Reports Second Quarter 2022 Financial Results

Published: 08/04/2022 20:52 GMT
Cytokinetics Inc (CYTK) - Cytokinetics Reports Second Quarter 2022 Financial Results.
Q2 Loss per Share $0.23.
Expects to End 2022 With More Than $800 Million, Representing Between Two and Three Years of Forward Cash.
Qtrly Total Revenues $88.97 Million Versus $2.84 Million.
Q2 Earnings per Share View $-1.02, Revenue View $3.6 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $3.16 Million
Adjusted EPS is expected to be -$1.17

Next Quarter Revenue Guidance is expected to be $8.52 Million
Next Quarter EPS Guidance is expected to be -$1.13

More details on our Analysts Page.